Sponsored By ADVAlight;
There is no shortage of versatility claims in the aesthetic industry, but few devices deliver on those claims. One powerful example is the dual wavelength ADVATx laser system from Advalight (Copenhagen, Denmark), whose 589 nm and 1319 nm wavelengths can be used individually or concurrently. With 25 FDA-/CE-cleared applications to date, the ability to treat patients of virtually any age or skin type, and the advantage of no consumables, the ADVATx’s utility gives it workhorse status, and the robust platform is up to the challenge.
This dynamic device is effective as a stand-alone treatment with many iterations using its two wavelengths, but it also excels at elevating other procedures and therapies to the next level. Donna Stockton, MD, a dermatologist at Dermatology and Skin Surgery Associates in Mokena, Ill., relies on the ADVATx device and uses it all throughout the day, every day the practice is open – making the lack of consumables a helpful advantage, among others. In addition, pre- and post-treatment protocols are minimal due to the tunability of the laser, making treatment time more manageable.
“I love it for acne and rosacea, but we are always finding other uses for it,” Dr. Stockton stated. “We are continually surprised by its utility and the way it can augment so many procedures. For instance, I go over all of my surgical scars with it because it reduces the redness, which patients absolutely love. Our estheticians also use it for fine lines and wrinkles as well as for finishing up at the end of lighter treatments, like facials, to smooth out the skin and reduce pore size. As patients repeatedly describe, it gives them a ‘glow.’”
ADVATx employs complementary 589 nm and 1319 nm wavelengths that can be emitted individually or concurrently via proprietary PulSync Technology. This involves the novel use of Q-switching, a YAG crystal, and a non-linear lithium triborate (LBO) crystal to craft a 589 nm beam out of a 1319 beam from a second emitter.
The yellow 589 nm wavelength is the gold standard for redness and unwanted vascularity, but has also recently been demonstrated to reduce porphyrins,* a key aspect of inflammation management that can have a positive effect on many skin conditions. With water as its chromophore, the 1319 nm wavelength is a known powerhouse for thermally generated dermal collagen remodeling.
“I – and I think many of us – used to look at things as one diagnosis at a time, whether it is a laser or intense pulsed light (IPL) or anything else,” Dr. Stockton noted. “Now I can treat many things on the face at once. A great example is ADVATx for treating rosacea, on the spectrum of skin types, including skin of color; it is the redness that bothers the patient, and we see immediate relief from that. It will also address any discolorations or hyperpigmentation, and there is a certain anti-inflammatory aspect as well which helps improve acne. When a patient lies down on the table hoping for reduced redness, they get a unique trifecta of improvements beyond that. ADVATx provides the kind of outcomes for which patients seek maintenance treatments, and readily tell their friends about. We do excellent work here, but that is a level of response and dramatic patient satisfaction I do not see with other modalities.”
*Data on file, Advalight (Copenhagen, Denmark)